10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2009 | |||
Statement Of Cash Flows Indirect | |||
Period Ending Dec 31, 2009 10-K (Filed: Mar 1, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Cash flows from operating activities: | |||
| Net income | $ 4,605 | 4,052 | 3,078 |
| Depreciation and amortization | 1,049 | 1,073 | 1,202 |
| Write-off of acquired in-process research and development | 0 | 0 | 590 |
| Stock-based compensation expense | 284 | 262 | 263 |
| Deferred income taxes | 47 | (137) | 56 |
| Property, plant and equipment impairments | 21 | 59 | 404 |
| Dividend received from equity investee | 110 | 8 | 76 |
| Other items, net | 111 | 244 | 173 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (36) | 65 | 38 |
| Inventories | (134) | (59) | (109) |
| Other current assets | (3) | 15 | (119) |
| Accounts payable | 71 | 95 | (181) |
| Accrued income taxes | (142) | 14 | (810) |
| Other accrued liabilities | 320 | (30) | 688 |
| Deferred revenue | 33 | 327 | 52 |
| Net cash provided by operating activities | 6,336 | 5,988 | 5,401 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (530) | (672) | (1,267) |
| Cash paid for acquisitions, net of cash acquired | 0 | (56) | (697) |
| Purchases of marketable securities | (12,418) | (10,345) | (5,579) |
| Proceeds from sales of marketable securities | 8,252 | 6,762 | 5,073 |
| Proceeds from maturities of marketable securities | 1,443 | 1,018 | 454 |
| Other | 51 | 128 | 24 |
| Net cash used in investing activities | (3,202) | (3,165) | (1,992) |
| Cash flows from financing activities: | |||
| Repurchases of common stock | (3,208) | (2,268) | (5,100) |
| Repayment of debt | (1,000) | (2,000) | (1,840) |
| Net proceeds from issuance of debt | 1,980 | 991 | 3,982 |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 171 | 155 | 277 |
| Other | 33 | 49 | 13 |
| Net cash used in financing activities | (2,024) | (3,073) | (2,668) |
| Increase (decrease) in cash and cash equivalents | 1,110 | (250) | 741 |
| Cash and cash equivalents at beginning of period | 1,774 | 2,024 | |
| Cash and cash equivalents at end of period | 2,884 | 1,774 | 2,024 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |